N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry

scientific article

N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.75.15.7078-7085.2001
P8608Fatcat IDrelease_o5sb5flyl5hijasnxxvwm5jimm
P932PMC publication ID114436
P698PubMed publication ID11435588
P5875ResearchGate publication ID11904638

P2093author name stringM Watanabe
J C de la Torre
M A Whitt
M Perez
P2860cites workVesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.Q39869009
Adenovirus uncoating and nuclear establishment are not affected by weak base aminesQ39874543
Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.Q40039339
Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G.Q40039993
Characterization of a Borna disease virus glycoprotein, gp18.Q40042199
Molecular biology of borna disease virus: prototype of a new group of animal virusesQ40042752
Human infections with Borna disease virus and potential pathogenic implications.Q40549646
Natural and experimental Borna disease in animalsQ40549654
Borna disease--neuropathology and pathogenesis.Q40549665
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA virusesQ40551514
Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusionQ40976386
Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitnessQ41067283
Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridizationQ41790548
Sequence characterization of human Borna disease virusQ42641464
In vitro studies on Borna virus. I. The use of cell cultures for the demonstration, titration and production of Borna virusQ44207080
Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cellsQ44569184
Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cellsQ45740287
Proteolytic processing of Marburg virus glycoproteinQ45744301
Effects of double-site mutations of vesicular stomatitis virus glycoprotein G on membrane fusion activityQ45750581
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study GroupQ45760949
Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patientsQ45768244
Borna disease virus genome transcribed and expressed in psychiatric patientsQ45788458
Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cellsQ45789227
The interaction of antibody with the major surface glycoprotein of vesicular stornatitis virus II. Monoclonal antibodies to nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypesQ45805145
Attenuated vesicular stomatitis viruses as vaccine vectorsQ27469358
Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virusQ27469536
A fusion-defective mutant of the vesicular stomatitis virus glycoproteinQ27486497
Efficient selection for high-expression transfectants with a novel eukaryotic vectorQ27860810
Product review. New mammalian expression vectorsQ29620743
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.Q33783176
Biochemical analysis of the secreted and virion glycoproteins of Ebola virusQ33783398
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challengeQ33783986
The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assemblyQ33798704
Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteinsQ33803482
Isolation of Borna disease virus from human brain tissueQ33804447
Pathogenesis of borna disease virus: granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral antibodies.Q33816410
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clonesQ33975389
Epidemiology of Borna disease virusQ34009974
Recombinant vesicular stomatitis viruses from DNA.Q34337129
Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface.Q35842415
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.Q35872114
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.Q35889961
Processing of the Ebola virus glycoprotein by the proprotein convertase furinQ36098653
Sequence conservation in field and experimental isolates of Borna disease virus.Q36618782
A system for functional analysis of Ebola virus glycoproteinQ36831630
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cellsQ37326413
Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entryQ38559106
Borna disease virus: implications for human neuropsychiatric illnessQ38573259
In vitro studies on Borna virus. II. Properties of the virusQ39291445
Borna disease: a persistent virus infection of the central nervous systemQ39529919
Mechanism of Borna disease virus entry into cellsQ39577476
Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furinQ39578848
Domains of virus glycoproteins.Q39657267
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectBorna diseaseQ9430213
BornavirusQ9428680
P1104number of pages8
P304page(s)7078-7085
P577publication date2001-08-01
P1433published inJournal of VirologyQ1251128
P1476titleN-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry
P478volume75

Reverse relations

cites work (P2860)
Q45857343A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury
Q38960717A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region
Q40039979Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.
Q35217191Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors
Q56972248Borna Disease Virus
Q37941939Borna disease virus - fact and fantasy
Q40132968Borna disease virus glycoprotein is required for viral dissemination in neurons.
Q38183555Borna disease virus infection in cats.
Q38904470Borna disease virus possesses an NF-ĸB inhibitory sequence in the nucleoprotein gene
Q43173410Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry
Q39816452Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules
Q42737894Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein
Q36510369Cells expressing the RING finger Z protein are resistant to arenavirus infection
Q40043231Cellular entry of lymphocytic choriomeningitis virus
Q40509716Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan
Q28681321Comprehensive analysis of endogenous bornavirus-like elements in eukaryote genomes
Q35679152Development and Applications of VSV Vectors Based on Cell Tropism
Q40155846Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus
Q33657931Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
Q39610326Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen
Q40692191Identification of the amino terminal subunit of the glycoprotein of Borna disease virus
Q39683612Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles
Q33652265Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers
Q45426950Maturation of Borna disease virus glycoprotein
Q34121989Molecular and cellular biology of Borna disease virus infection
Q39795978Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface
Q39684747Persistence of Borna disease virus in naturally infected sheep
Q34123911Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.
Q27489799Proteomics computational analyses suggest that the bornavirus glycoprotein is a class III viral fusion protein (γ penetrene)
Q35147223Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein
Q45412343Reverse-genetic approaches to the study of Borna disease virus
Q37252717Role of DC-SIGN in Lassa virus entry into human dendritic cells
Q34743550Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication
Q41922444Studies of Lassa Virus Cell Entry
Q41019795Surface glycoprotein of Borna disease virus mediates virus spread from cell to cell
Q40686662Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding
Q39713991Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test

Search more.